These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3839851)

  • 1. Adriamycin analogues. rationale, synthesis, and preliminary antitumor evaluation of highly active DNA-nonbinding N-(trifluoroacetyl)adriamycin 14-O-hemiester derivatives.
    Israel M; Potti PG; Seshadri R
    J Med Chem; 1985 Sep; 28(9):1223-8. PubMed ID: 3839851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin analogues. Preparation and biological evaluation of some N-(trifluoroacetyl)-14-O-[(N-acetylamino)acyl]adriamycin derivatives.
    Israel M; Taube D; Seshadri R; Idriss JM
    J Med Chem; 1986 Jul; 29(7):1273-6. PubMed ID: 3806576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin analogues. Preparation and biological evaluation of some N-perfluoroacyl analogues of daunorubicin, adriamycin, and N-(trifluoroacetyl)adriamycin 14-valerate and their 9,10-anhydro derivatives.
    Israel M; Potti G
    J Med Chem; 1982 Feb; 25(2):187-91. PubMed ID: 7057426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin analogues. Preparation and biological evaluation of some thio ester analogues of adriamycin and N-(trifluoroacetyl)adriamycin 14-valerate.
    Seshadri R; Idriss JM; Israel M
    J Med Chem; 1986 Jul; 29(7):1269-73. PubMed ID: 3806575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin analogues. Preparation and biological evaluation of some novel 14-thiaadriamycins.
    Seshadri R; Israel M; Pegg WJ
    J Med Chem; 1983 Jan; 26(1):11-5. PubMed ID: 6827523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of N-trifuloroacetyladriamycin-14-valerate.
    Pratesi G; Casazza AM; Di Marco A
    Cancer Treat Rep; 1978 Jan; 62(1):105-10. PubMed ID: 626988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin analogues. Preparation of 9,10-anhydrodaunorubicin, 9,10-anhydroadriamycin, and some related compounds.
    Potti G; Israel M
    J Med Chem; 1982 Apr; 25(4):478-81. PubMed ID: 6951049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-trifluoroacetyladriamycin-14-valerate, an analog with greater experimental antitumor activity and less toxicity than adriamycin.
    Israel M; Modest EJ; Frei E
    Cancer Res; 1975 May; 35(5):1365-8. PubMed ID: 1054622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calmodulin inhibitor trifluoperazine selectively enhances cytotoxic effects of strong vs weak DNA binding antitumor drugs in doxorubicin-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Schmidt H; Seshadri R; Israel M
    Biochem Biophys Res Commun; 1985 Sep; 131(2):912-9. PubMed ID: 2932108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin analogues. Preparation and antitumor evaluation of 7-O-(beta-D-glucosaminyl)daunomycinone and 7-O-(beta-D-glucosaminyl)adriamycinone and their N-trifluoroacetyl derivatives.
    Israel M; Murray RJ
    J Med Chem; 1982 Jan; 25(1):24-8. PubMed ID: 7086817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3'-Hydroxyesorubicin. Synthesis and antitumor activity.
    Priebe W; Neamati N; Perez-Soler R
    J Antibiot (Tokyo); 1990 Jul; 43(7):838-46. PubMed ID: 2387778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin 14-ethers.
    Masi P; Suarato A; Giardino P; Bernardi L; Arcamone F
    Farmaco Sci; 1979 Oct; 34(10):907-13. PubMed ID: 510533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric monitoring of cellular anthracycline accumulation in murine leukemic cells.
    Krishan A; Sauerteig A; Gordon K; Swinkin C
    Cancer Res; 1986 Apr; 46(4 Pt 1):1768-73. PubMed ID: 3948163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-salicylidene derivatives of pirarubicin.
    Ajito K; Ikeda D; Komuro K; Nosaka C; Wako N; Kondo S; Takeuchi T
    J Antibiot (Tokyo); 1989 Jul; 42(7):1133-44. PubMed ID: 2753818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antitumour activity of new daunorubicin and adriamycin analogues.
    Arcamone F; Bernardi L; Patelli B; Giardino P; Di Marco A; Casazza AM; Soranzo C; Pratesi G
    Experientia; 1978 Oct; 34(10):1255-7. PubMed ID: 570116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of adriamycin cytotoxicity in P388 murine leukemia sensitive and resistant to adriamycin by use of lonidamine and hyperthermia.
    Chitnis M; Adwankar M
    Tumori; 1986 Oct; 72(5):469-73. PubMed ID: 3798566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
    Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor properties of new glycosides of daunomycinone and adriamycinone.
    Arcamone F; Penco S; Vigevani A; Redaelli S; Franchi G; DiMarco A; Casazza AM; Dasdia T; Formelli F; Necco A; Soranzo C
    J Med Chem; 1975 Jul; 18(7):703-7. PubMed ID: 168385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
    Lepri E; Menconi E; Barzi AM
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.